KALARIS THERAPEUTICS INC

KLRS · NASDAQ

Updated at 2026-10-18 00:38:31

$2.00-8.67%
Today's High
$2.29
Today’s Low
$2.00
KALARIS THERAPEUTICS INC (KLRS) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$2.25
Previous Close
$2.00
Volume
58.31K
Market Cap
$43.68M
P/E Ratio
--
EPS
$-2.09

Previous Day Range

$2.00$2.29

52-Week Range

$2.10$11.88

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
400 CONNELL DRIVE, BERKELEY HEIGHTS, NJ, UNITED STATES, 07922
Country
US
Listing Date
2020-07-30
Fiscal Year End
December
Shares Outstanding
23.79M
CIK
0001754068

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. The company is headquartered in Palo Alto, California.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$12.38M

2026-03-31

$11.82M

2025-12-31

$10.79M

2025-09-30

$12.74M

Net Income

2026-06-30

-$11.51M

2026-03-31

-$10.85M

2025-12-31

-$9.99M

2025-09-30

-$11.89M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.48

2026-03-31

$-0.46

2025-12-31

$-0.44

2025-09-30

$-0.64

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$12.37M

2026-03-31

-$10.84M

2025-12-31

-$9.98M

2025-09-30

-$11.89M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.